Related references
Note: Only part of the references are listed.Synthesis and Characterization of New N-Alkylamino-3,5-diphenylpyrazole Ligands and Reactivity Toward Pd-II and Pt-II. Study of the cis-trans Isomerization
Gemma Aragay et al.
AUSTRALIAN JOURNAL OF CHEMISTRY (2010)
The status of platinum anticancer drugs in the clinic and in clinical trials
Nial J. Wheate et al.
DALTON TRANSACTIONS (2010)
Crystal structures of Pt(II) and Pd(II) complexes with the free radical 4-aminoTEMPO
Christian Tessier et al.
INORGANICA CHIMICA ACTA (2010)
Synthesis, X-ray crystal structure and NMR characterisation of mononuclear Pd(II) and Pt(II) complexes of didentate ligands with NN′-donor set
Josefina Pons et al.
INORGANICA CHIMICA ACTA (2010)
Recent strategy for the management of advanced testicular cancer
Terukazu Nakamura et al.
INTERNATIONAL JOURNAL OF UROLOGY (2010)
Biological activity of enantiomeric complexes [PtCl2L2] (L2 is aromatic bisphosphanes and aromatic diamines)
Sophie Bombard et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2010)
Tricarbonyl M(I) (M = Re, Tc-99m) complexes bearing acridine fluorophores: synthesis, characterization, DNA interaction studies and nuclear targeting
Teresa Esteves et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2010)
99mTc-Tricarbonyl Complexes Functionalized with Anthracenyl Fragments: Synthesis, Characterization, and Evaluation of Their Radiotoxic Effects in Murine Melanoma Cells
Rute F. Vitor et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2009)
The Relevance of Polar Surface Area (PSA) in Rationalizing Biological Properties of Several cis-Diamminemalonatoplatinum(II) Derivatives
Giulia Caron et al.
CHEMMEDCHEM (2009)
Variable Coordination Behavior of New Hybrid Pyrazole Ligand: Synthesis and Characterization of Several ZnII, CdII, HgII, PdII, PtII, and NiII Complexes
Miguel Guerrero et al.
INORGANIC CHEMISTRY (2009)
Phase II Study of Picoplatin As Second-Line Therapy for Patients With Small-Cell Lung Cancer
John R. Eckardt et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Re and Tc Complexes with Pyrazolyl-Containing Chelators: from Coordination Chemistry to Target-Specific Delivery of Radioactivity
Joao D. G. Correia et al.
CURRENT RADIOPHARMACEUTICALS (2009)
The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy
Matthew D. Hall et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Pyrazolyl-diamine ligands that bear anthracenyl moieties and their rhenium(I) tricarbonyl complexes: Synthesis, characterisation and DNA-binding properties
Rute F. Vitor et al.
CHEMBIOCHEM (2008)
Synthetic Route to Dinuclear Platinum(II) Complexes [{trans-PtCl(NH3)2}2(μ-L)]2+ (L = Aliphatic or Heterocyclic Diamine) as Potential Antitumor Agents, Exploiting the Mutual Activation of Hydroxido Ligands and Ammonium Groups
Claude Chopard et al.
INORGANIC CHEMISTRY (2008)
Synthesis of new platinum(II) compounds with several bidentate and tridentate nitrogen-donor ligands.: Structural analyses by 1H, 13C{1H} and 195Pt{1H} NMR spectroscopy and X-ray crystal structure
M. del Carme Castellano et al.
INORGANICA CHIMICA ACTA (2008)
Trend in cytotoxic activity of a series of cis-[APtCl2] (A = ethylenediamine methylated at different positions) complexes
Marco Milanesio et al.
INORGANICA CHIMICA ACTA (2008)
The influence of temperature on antiproliferative effects, cellular uptake and DNA platination of the clinically employed Pt(II)-drugs
Elisabetta Gabano et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2008)
cis-diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent:: Uptake, structure, function, and prospects
Katherine S. Lovejoy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Pt-195 NMR - theory and application
Brett M. Still et al.
CHEMICAL SOCIETY REVIEWS (2007)
Rhenium(V) oxocomplexes with novel pyrazolyl-based N4- and N3S-donor chelators
Carolina Moura et al.
DALTON TRANSACTIONS (2006)
Three new asymmetric trans-amine(azole)dichloridoplatinum complexes that overcome cisplatin resistance and their reactions with 5′-GMP
Elena Pantoja et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
The RP-HPLC measurement and QSPR analysis of log Po/w values of several Pt(II) complexes
James A. Platts et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
Metal-based antitumour drugs in the post genomic era
PJ Dyson et al.
DALTON TRANSACTIONS (2006)
Activation of carboplatin by carbonate
AJ Di Pasqua et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2006)
Virtual computational chemistry laboratory - design and description
IV Tetko et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2005)
Model platinum nucleobase and nucleoside complexes and antitumor activity:: X-ray crystal structure of [PtIV(trans-1 R,2R-diaminocyclohexane) trans-(acetate)2(9-ethylguanine)Cl]NO3 • H2O
MS Ali et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2005)
Pyrazolyl derivatives as bifunctional chelators for labeling tumor-seeking peptides with the fac-[M(CO)3]+ moiety (M=99mTc, Re):: Synthesis, characterization, and biological behavior
S Alves et al.
BIOCONJUGATE CHEMISTRY (2005)
Cytotoxicity of cis-platinum(II) conjugate models.: The effect of chelating arms and leaving groups on cytotoxicity:: A quantitative structure-activity relationship approach
E Monti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS)
A Ghezzi et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
Multinuclear NMR study and crystal structures of complexes of the types cis- and trans-Pt(amine)2I2
FD Rochon et al.
INORGANICA CHIMICA ACTA (2004)
cis-1,4-diaminocyclohexane-Pt(II) and -(IV) adducts with DNA bases and nucleosides
MS Ali et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2003)
Reaction of (C-(6-aminomethyl-pyridin-2-yl)methylamine)chloroplatinum(II) with nucleosides and its biological activity
SWA Bligh et al.
DALTON TRANSACTIONS (2003)
A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole
S Komeda et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Glutathione induces cellular resistance against cationic dinuclear platinum anticancer drugs
BAJ Jansen et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2002)
Coordination capabilities of pyrazolyl containing ligands towards the fac-[Re(CO)(3)](+) moiety
S Alves et al.
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS (2002)
Calculation of the hydrophobicity of platinum drugs
JA Platts et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Synthesis and spectroscopic and structural characterization of different configurations of the tridentate amine ligand N,N′,N-trimethyldiethylenetriamine coordinated to platinum
NG Di Masi et al.
INORGANICA CHIMICA ACTA (2000)
Synthesis and characterization of Pt(II) complexes with amine and carboxylato ligands.: Crystal structure of (1,1-cyclobutanedicarboxylato)di(ethylamine)platinum(II)•H2O
FD Rochon et al.
INORGANICA CHIMICA ACTA (2000)